In-Hospital Adverse Events Similar for Haloperidol, Atypical Antipsychotics
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Sept. 6, 2023 -- For older patients without psychiatric disorders prescribed oral antipsychotic drugs after major surgery, the risks for in-hospital adverse events are comparable for haloperidol and atypical antipsychotics, according to a study published online Sept. 5 in the Annals of Internal Medicine.
Dae Hyun Kim, M.D., Sc.D., from Brigham and Women's Hospital in Boston, and colleagues conducted a retrospective cohort study involving 17,115 patients aged 65 years and older without psychiatric disorders who were prescribed an oral antipsychotic drug after major surgery to compare the risk for in-hospital adverse events. After propensity score overlap weighting, the risk ratios for in-hospital death, cardiac arrhythmia events, pneumonia, and stroke or transient ischemic attack (TIA) were estimated.
Of the four antipsychotics, quetiapine was the most prescribed (53.0 percent). The researchers found that the risk for in-hospital death did not differ significantly for patients treated with haloperidol (3.7 percent, reference), olanzapine, quetiapine, and risperidone (2.8, 2.6, and 3.3 percent, respectively). No significant differences were seen between the treatment groups for the risk for nonfatal clinical events (range, 2.0 to 2.6 percent for a cardiac arrhythmia event; 4.2 to 4.6 percent for pneumonia; and 0.6 to 1.2 percent for stroke or TIA).
"We recommend reducing antipsychotic use altogether as there is no safer antipsychotic drug option and focusing concerted clinical and health policy efforts and investment in nonpharmacologic interventions for delirium prevention and management," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Allergy-Related Psychological Distress Common
TUESDAY, July 2, 2024 -- Psychological distress related to food allergies (FA) is common globally, according to a study published online June 21 in Allergy. Rebecca C...
Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...
Emergence of Psychosis in Alzheimer Disease Linked to Elevations in p-tau181
MONDAY, July 1, 2024 -- For individuals with Alzheimer disease (AD), the emergence of psychosis is associated with elevations in levels of plasma tau phosphorylated at threonine...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.